- ENGLISH
- About JBIC
- Members
Corporate members (45 companies)
as of July11,2023
- Ajinomoto Co., Inc.
- Astellas Pharma Inc.
- Azenta Japan Corp.
- Canon Inc.
- CANON MEDICAL SYSTEMS CORPORATION
- CellFree Sciences Co., Ltd.
- CeSPIA Inc.
- Chiral Ltd.
- CHUGAI PHARMACEUTICAL CO., LTD.
- DAIICHI SANKYO COMPANY, LIMITED
- DAIICHI SANKYO RD NOVARE CO., LTD.
- Eisai Co., Ltd.
- EIKEN CHEMICAL CO., LTD.
- FiatLux Corporation
- FUJIFILM Wako Pure Chemical Corporation
- FUJITSU LIMITED
- G&G Science Co., Ltd.
- Hitachi, Ltd.
- Hitachi Solutions East Japan,Ltd.
- IMSBIO Co., Ltd.
- iPS Academia Japan, Inc.
- Japanese Foundation for Cancer Research
- JEOL Ltd.
- KAN Research Institute, Inc.
- KM Biologics Co., Ltd.
- Kyowa Kirin Co., Ltd.
- Medicrome, Inc.
- Meiji Seika Pharma Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation
- MITSUI KNOWLEDGE INDUSTRY CO., LTD.
- NIPPON GENE CO., LTD.
- Nippon Kayaku Co., Ltd.
- OP BIO FACTORY Co., Ltd.
- Precision System Science Co., Ltd.
- RePHAGEN
- RIKEN GENESIS CO., LTD.
- SCRUM Inc.
- SHIMADZU CORPORATION
- Socium Inc.
- SRL, Inc.
- StaGen Co., Ltd.
- SYSMEX CORPORATION
- TAIHO PHARMACEUTICAL CO., LTD.
- TOA EIYO LTD.
- Toray Industries, Inc.
Supporting corporate members (2 company)
Supporting individual members (3 individual)
- Research and Development
- Fukushima TranslationalResearch Project
- The development of novel biomarkers stratifying cancer patients based on comprehensive understanding of cancer immunity with immunomonitoring strategies
- Development of innovative drug discovery technologies for middle-sized molecules / Development of production technologies for middle-sized molecules
- Development of innovative drug discovery technologies for middle-sized molecules / Development of simulation technologies for middle-sized molecules
Copyright © 2000-2019 Japan Biological Informatics Consortium All rights reserved.
